Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Aug 15, 2020; 12(8): 850-856
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.850
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.850
Type I | Type II | Type III | |
Prevalence, % | 70-80 | 5-10 | 10-20 |
Background | Chronic atrophic gastritis | Gastrinomas (Zollinger-Ellison syndrome) | Normal mucosa |
Other syndromes | Autoimmune polyglandular syndrome | MEN-1 syndrome | |
Number of lesions | Multiple | Multiple | Single |
Site of tumor | Fundus/body | Fundus/body | Fundus/body |
Cell of origin | ECL | ECL | ECL, EC or X cell |
Serum gastrin levels | Elevated | Elevated | Normal |
Gastric PH | High | Low | Normal |
Underlying mucosa | Atrophic | Hypertrophic | Normal |
Size of tumors, usual | 1-2 cm | 1 cm | > 2 cm |
Invasion | Rare | More common | Common |
Metastases | |||
Lymph nodes | 5%-10% | 10%-20% (duodenal tumors) | 50%-100% |
Liver | 2%-5% | 10% | 22%-75% |
Prognosis | Excellent | Very good | Similar to gastric adenocarcinoma |
- Citation: Roberto GA, Rodrigues CMB, Peixoto RD, Younes RN. Gastric neuroendocrine tumor: A practical literature review. World J Gastrointest Oncol 2020; 12(8): 850-856
- URL: https://www.wjgnet.com/1948-5204/full/v12/i8/850.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i8.850